MDA Ltd.
MDA Ltd. (MDALF) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for MDA Ltd. (MDALF), covering cash flow, earnings, and balance sheets.
MDA Ltd. (MDALF) Income Statement & Financial Overview
Review MDA Ltd. MDALF income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $351.00M | $346.60M | $282.40M | $242.00M |
| Cost of Revenue | $271.30M | $264.70M | $206.70M | $175.80M |
| Gross Profit | $79.70M | $81.90M | $75.70M | $66.20M |
| Gross Profit Ratio | $0.23 | $0.24 | $0.27 | $0.27 |
| R&D Expenses | $5.50M | $11.90M | $7.20M | $8.80M |
| SG&A Expenses | $27.30M | $24.50M | $21.40M | $23.70M |
| Operating Expenses | $44.40M | $47.90M | $40.20M | $44.10M |
| Total Costs & Expenses | $315.70M | $312.60M | $246.90M | $219.90M |
| Interest Income | $1.70M | $3.30M | $2.30M | $700000.00 |
| Interest Expense | $4.90M | $9.60M | $4.40M | $7.90M |
| Depreciation & Amortization | $25.30M | $24.40M | $21.30M | $22.50M |
| EBITDA | $75.50M | $70.40M | $66.30M | $44.90M |
| EBITDA Ratio | $0.22 | $0.20 | $0.23 | $0.19 |
| Operating Income | $35.30M | $34.00M | $35.50M | $22.10M |
| Operating Income Ratio | $0.10 | $0.10 | $0.13 | $0.09 |
| Other Income/Expenses (Net) | $10.00M | $2.40M | $5.10M | -$7.60M |
| Income Before Tax | $45.30M | $36.40M | $40.60M | $14.50M |
| Income Before Tax Ratio | $0.13 | $0.11 | $0.14 | $0.06 |
| Income Tax Expense | $12.40M | $11.30M | $11.10M | $3.50M |
| Net Income | $32.90M | $25.10M | $29.50M | $11.00M |
| Net Income Ratio | $0.09 | $0.07 | $0.10 | $0.05 |
| EPS | $0.27 | $0.21 | $0.25 | $0.09 |
| Diluted EPS | $0.26 | $0.20 | $0.24 | $0.09 |
| Weighted Avg Shares Outstanding | $122.24M | $121.53M | $120.11M | $120.06M |
| Weighted Avg Shares Outstanding (Diluted) | $127.59M | $127.44M | $124.29M | $123.52M |
Over the last four quarters, MDA Ltd. achieved steady financial progress, growing revenue from $242.00M in Q2 2024 to $351.00M in Q1 2025. Gross profit stayed firm with margins at 23% in Q1 2025 versus 27% in Q2 2024. Operating income totaled $35.30M in Q1 2025, maintaining a 10% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $75.50M. Net income rose to $32.90M, with EPS at $0.27. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan